Cargando…

The Diagnostic Performance of Afirma Gene Expression Classifier for the Indeterminate Thyroid Nodules: A Meta-Analysis

BACKGROUND: Approximately 15 to 30% of thyroid nodules evaluated by fine-needle aspiration (FNA) were classified as indeterminate; the accurate diagnostic molecular tests of these nodules remain a challenge. We aimed to evaluate the diagnostic performance of Afirma gene expression classifier (GEC) f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ying, Pan, Bihui, Xu, Li, Fang, Da, Ma, Xianghua, Lu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720051/ https://www.ncbi.nlm.nih.gov/pubmed/31531363 http://dx.doi.org/10.1155/2019/7150527

Ejemplares similares

Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
por: Hao, Yangyang, et al.
Publicado: (2019)

Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study †
por: Kandil, Emad, et al.
Publicado: (2023)

Shear wave elastography and Afirma™ gene expression classifier in thyroid nodules with indeterminate cytology: a comparison study
por: Azizi, Ghobad, et al.
Publicado: (2018)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

Use of the Afirma® Gene Expression Classifier for Preoperative Identification of Benign Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytopathology
por: Ali, Syed Z., et al.
Publicado: (2013)

MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020)

Prevalence of cancer and the benign call rate of afirma gene classifier in (18)F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules
por: Endo, Mayumi, et al.
Publicado: (2021)

Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules
por: Jin, Xiaobing, et al.
Publicado: (2022)

Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making
por: Kloos, Richard T.
Publicado: (2017)

Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
por: Hu, Mimi I, et al.
Publicado: (2021)

Diagnostic performance of ultrasound risk stratification systems on thyroid nodules cytologically classified as indeterminate: a systematic review and meta-analysis
por: Xing, Zhichao, et al.
Publicado: (2023)

Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes
por: Baca, Sylvan C., et al.
Publicado: (2017)

Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022)

Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis
por: Silaghi, Cristina Alina, et al.
Publicado: (2021)

LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) - A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022)

Diagnostic performance of shear wave elastography in thyroid nodules with indeterminate cytology: A systematic review and meta-analysis
por: Qiu, Yuxuan, et al.
Publicado: (2023)

The first Canadian experience with the Afirma® gene expression classifier test
por: Kay-Rivest, Emily, et al.
Publicado: (2017)

Multiplatform molecular test performance in indeterminate thyroid nodules
por: Lupo, Mark A., et al.
Publicado: (2020)

A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study
por: González, Hernán E., et al.
Publicado: (2017)

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study
por: Steward, David L., et al.
Publicado: (2018)

Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules
por: Zhou, Le, et al.
Publicado: (2021)

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier
por: Randolph, Gregory W., et al.
Publicado: (2022)

Indeterminate Thyroid Nodules: When to Worry?
por: Tibbels, Amanda
Publicado: (2023)

SUN-LB24 Clinical Performance of Multiplatform Mutation Panel MicroRNA Risk Classifier in Indeterminate Thyroid Nodules
por: Sistrunk, J Woody, et al.
Publicado: (2020)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

TIRADS, SRE and SWE in INDETERMINATE thyroid nodule characterization: Which has better diagnostic performance?
por: Celletti, Ilaria, et al.
Publicado: (2021)

MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019)

Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2019)

Local molecular analysis of indeterminate thyroid nodules
por: Gill, Mandeep S., et al.
Publicado: (2015)

A Pragmatic Approach to the Indeterminate Thyroid Nodule
por: Seshadri, Krishna G.
Publicado: (2017)

Indeterminate thyroid nodules in the era of molecular genomics
por: Rao, Sarika N., et al.
Publicado: (2020)

LBODP107 Real World Performance Of The Afirma Xpression Atlas In Bethesda III And IV Thyroid Nodules. A Private Practice Experience
por: Ortega, Dayron, et al.
Publicado: (2022)

Acto que afirma
por: Meléndez, Juana
Publicado: (1976)

Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules
por: Vachani, Anil, et al.
Publicado: (2015)

Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
por: Sciacchitano, Salvatore, et al.
Publicado: (2017)

MON-569 Performance of American Thyroid Association Sonographic Risk and Gene Expression Classifier in the Diagnosis of Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytology
por: Arosemena, Marilyn, et al.
Publicado: (2019)

MON-525 ATA and ACR TIRADS Classification Systems as Additional Predictors of Malignancy in Afirma GSC Suspicious Thyroid Nodules
por: Azaryan, Irina, et al.
Publicado: (2020)

Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3
por: Kim, Na Eun, et al.
Publicado: (2023)

THU678 Real-world Performance Of Afirma Genomic Sequencing Classifier (GSC) In A Community Healthcare Setting
por: Master, Vidisha, et al.
Publicado: (2023)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3dok6ggeot8uc2ak7fn5dam48f